Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 1, 2015The American Journal of Gastroenterology

Long-Term Therapy With Bevacizumab in a Patient With Glanzmann’s Thrombasthenia and Recurrent Digestive Bleeding due to Gastrointestinal Angiodysplastic Lesions

View Full Paper
Ask AI
Bookmark
Share

Authors

RMRaphaël MarluCentre National de la Recherche ScientifiqueJBJustine BarthelonCentre National de la Recherche ScientifiqueADAurélie DurandCentre National de la Recherche Scientifique

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Marlu et al. (2015) studied this question.

synapsesocial.com/papers/6a9de413d1e929bd30d9e262https://doi.org/10.1038/ajg.2014.391
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Bevacizumab in Patients With Hereditary Hemorrhagic Telangiectasia and Severe Hepatic Vascular Malformations and High Cardiac Output2012 · 388 citations
  2. 2Management of Gastrointestinal Angiodysplastic Lesions (GIADs): A Systematic Review and Meta-Analysis2014 · 175 citations
  3. 3Long-Term Therapy with Bevacizumab in Hereditary Hemorrhagic Telangiectasia2011 · 40 citations
  4. 4Thalidomide sensory neurotoxicity2004 · 135 citations
  5. 5Bevacizumab as Rescue Treatment for Severe Recurrent Gastrointestinal Bleeding in Hereditary Hemorrhagic Telangiectasia2012 · 40 citations